Evidence map›Paper›PMID 25340820›Full record

ArticlePLoS pathogens2014

HPV16-E7 expression in squamous epithelium creates a local immune suppressive environment via CCL2- and CCL5- mediated recruitment of mast cells.

Anne-Sophie Bergot, Neill Ford, Graham R Leggatt, James W Wells, Ian H Frazer, Michele A Grimbaldeston

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Article
  3. Deciphering the Role of Mast Cells in HPV-Related Cancers.International journal of molecular sciences · 2025
    Review
  4. Article
  5. Article
  6. Review
  7. Novel gene signatures predicting and immune infiltration analysis in Parkinson's disease: based on combining random forest with artificial neural network.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Immunotherapy for HPV associated cancer.Papillomavirus research (Amsterdam, Netherlands) · 2019
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Anne-Sophie BergotThe University of Queensland Diamantina Institute, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
Neill FordThe University of Queensland Diamantina Institute, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
Graham R LeggattThe University of Queensland Diamantina Institute, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
James W WellsThe University of Queensland Diamantina Institute, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
Ian H FrazerThe University of Queensland Diamantina Institute, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
Michele A GrimbaldestonDivision of Human Immunology, Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, South Australia, Australia.
Princess Alexandra Hospital · AUUniversity of South Australia · AU

Funding

Novel Interventions Against HPV-associated NeoplasiaU01CA141583 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI LAMBERT, PAUL F., MUNGER, KARL · 2009 to 2013
$3.8M
NCI NIH HHS 5U01CA141583NCI NIH HHS U01 CA141583
6 · The paper itself

Abstract

Human Papillomavirus (HPV) 16 E7 protein promotes the transformation of HPV infected epithelium to malignancy. Here, we use a murine model in which the E7 protein of HPV16 is expressed as a transgene in epithelium to show that mast cells are recruited to the basal layer of E7-expressing epithelium, and that this recruitment is dependent on the epithelial hyperproliferation induced by E7 by inactivating Rb dependent cell cycle regulation. E7 induced epithelial hyperplasia is associated with increased epidermal secretion of CCL2 and CCL5 chemokines, which attract mast cells to the skin. Mast cells in E7 transgenic skin, in contrast to those in non-transgenic skin, exhibit degranulation. Notably, we found that resident mast cells in E7 transgenic skin cause local immune suppression as evidenced by tolerance of E7 transgenic skin grafts when mast cells are present compared to the rejection of mast cell-deficient E7 grafts in otherwise competent hosts. Thus, our findings suggest that mast cells, recruited towards CCL2 and CCL5 expressed by epithelium induced to proliferate by E7, may contribute to an immunosuppressive environment that enables the persistence of HPV E7 protein induced pre-cancerous lesions.

Indexed as

AnimalsAnimals, Genetically ModifiedChemokine CCL2Chemokine CCL5EnvironmentEpitheliumHumansMast CellsMice, Inbred C57BLPapillomavirus E7 ProteinsSkinChemokine CCL2Chemokine CCL5oncogene protein E7, Human papillomavirus type 16Papillomavirus E7 Proteins

Identifiers

PMID25340820
PMCPMC4207828
OpenAlexW1983489364

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.